Anti-Human IL17A Recombinant Antibody(Bimekizumab)

Product Information

Catalog Number	YR1328
Product Name	Anti-Human IL17A Recombinant Antibody(Bimekizumab)
Molecular Name	Bimekizumab
Alias	Anti-IL17A Recombinant Antibody, Research Grade Bimekizumab
CAS Number	1418205-77-2
Target	IL17A[Homo sapiens]
Isotype	IgG1 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	ELISA, FCM, IP, FuncS, IF, Neut
Buffer	PBS, pH7.5
Background	Bimekizumab (INN) is a humanized anti-IL17A and IL-17F monoclonal antibody that is being investigated for ankylosing spondylitis, psoriatic arthritis, and psoriasis. This drug is being developed by Belgian pharmaceutical UCB. As of 2018, bimekizumab is undergoing Phase III trials.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price